A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno‐ontogenic principles

L. Tan
DOI: https://doi.org/10.1080/00313020902884501
2009-06-01
Abstract:&NA; This review aims to interrelate the major lymphoma types in the current World Health Organization (WHO) classification to construct a framework for understanding and diagnostic application. Multiple morphological, phenotypical and molecular genotypical data are assessed in order to categorise lymphomas into germinal centre (GC) and extracentric (EC) subgroups. GC entities [lymphocyte‐predominant Hodgkin, follicular, Burkitt's, angioimmunoblastic T‐cell and diffuse large B‐cell lymphoma (DLBCL) with GC profile] express bcl‐6, CD10 and/or the GC‐homing chemokine CXCL13, and harbour ongoing somatic hypermutations (SHM), but not Epstein–Barr virus (EBV) in its higher latency states. Post‐GC entities [classical Hodgkin, marginal zone and lymphoplasmacytic lymphomas, half of chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL), DLBCL with ‘activated’ or post‐GC profile, primary effusion lymphoma, plasmacytoma and myeloma] express, instead, MUM.1 and/or CD138, harbour static rather than ongoing SHM, and may harbour EBV in higher latency states. The remainder of CLL/SLL and the majority of mantle cell lymphoma without SHM constitute the pre‐GC (‘naïve’) category, with coexpression of IgD and CD5. Lymphomas can be categorised across lineage (B‐ or T‐cell) and relationship against host immune response (Hodgkin or non‐Hodgkin) into GC and EC groups, affording leverage in their differential diagnosis.
What problem does this paper attempt to address?